Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

PM

Philip Morris International Reports 9.1% Q1 Revenue Growth

Philip Morris International’s first-quarter net revenues rose 9.1% from a year earlier to $10.1 billion, with organic growth of 2.7%. Gross profit climbed 10.1% to $6.9 billion, while operating income increased 9.8% to $3.9 billion. Adjusted diluted EPS advanced 16.0% to $1.96, or 5.3% excluding currency, but reported diluted EPS fell 9.3% to $1.56.

The smoke-free business remained the main growth engine. International smoke-free net revenues jumped 24.7% to $3.8 billion, with organic growth of 15.8%. Gross profit in that segment rose 28.6% to $2.7 billion. Shipment volume increased 11.9% to 44.1 billion equivalent units.

Within smoke-free, heat-not-burn shipments rose 11.3% to 41.3 billion equivalent units. Oral smoke-free volume fell 5.1% to 1.6 billion equivalent units, while e-vapor shipments reached 1.29 billion equivalent units, up 94.8%. Smoke-free products made up 43% of total net revenues, up 1.3 percentage points from the prior year.

International combustibles net revenues increased 6.8% to $5.7 billion, with organic growth of 1.0%, even as shipment volume declined 5.1% to 137.3 billion equivalent units. Gross profit in combustibles rose 9.8% to $3.8 billion. Cigarette category volume share slipped 0.6 percentage points to 24.8%, while Marlboro’s share rose 0.4 percentage points to a first-quarter record 10.7%.

The U.S. segment moved the other way. Net revenues fell 30.8% to $622 million, with organic revenue down 31.6%. Total smoke-free shipment volumes in the U.S. dropped 21.2%, and Zyn shipments fell 23.5% to 2.3 billion pouches, or 155 million cans. U.S. adjusted gross profit declined 44.1% organically, and adjusted OCI dropped 75.3%.

For the full year, Philip Morris now expects adjusted diluted EPS of $8.36 to $8.51, up 10.9% to 12.9% from 2025. Excluding currency, that implies growth of 7.5% to 9.5% to a range of $8.11 to $8.26. The company previously reported 2025 adjusted diluted EPS of $7.54. Following these announcements, the company's shares moved -1.82%, and are now trading at a price of $162.49. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS